The hemoglobin monitor market is expected to record a CAGR of 7.8% during the forecast period 2022 to 2032, up from US$ 1 Billion in the year 2020 to reach a valuation of US$1.7 Billion by 2032.
The hemoglobin monitor market is anticipated to show promising growth prospects in the forecasted period 2022 to 2032.
With recent technological advances, smartphone applications equipped with algorithms to detect hemoglobin levels are changing future trends in hemoglobin monitoring. Furthermore, this shift towards non-invasive hemoglobin monitors is expected to affect the parent sector's business models and investment strategies.
Advances in technology and the modes and operations of hemoglobin monitors are changing the behavior of customers and end-users when purchasing these devices, and consequently increasing the hemoglobin monitor's market share.
| Report Attributes | Details |
|---|---|
| CAGR | 7.8% |
| Value (2022) | US$1 Billion |
| Value (2032) | US$1.7 Billion |
During the forecast period, there will be significant growth in the hemoglobin monitor market globally. The growth in blood donation creates more lucrative business opportunities for the hemoglobin monitor market, and companies currently operating on the market.
Hemoglobin monitors are a multifaceted market comprised of prominent innovators, regional distributors, and small players looking for survival. Each hemoglobin monitor uses a different type of mechanism and is used to deliver better clinical results.
With emerging trends in the hemoglobin monitor market, it is hoped that non-invasive hemoglobin monitors will ultimately replace traditional hemoglobin monitors, enabling hemoglobin monitor manufacturers to produce an optimal number of units. The continuous monitoring of blood will lead to an increase in demand for hemoglobin monitor manufacturing.
As important as the developed economies are to the industry, emerging economies are also moving at a good pace with regard to the adoption of the hemoglobin monitor market. Founded on the basis of quality infrastructure and an installed base that support hemoglobin monitor production, North America is estimated to have a significant market share in the hemoglobin monitor market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The cost associated with manufacturing a hemoglobin monitor is determined by its size, purpose, and features. Having recently been approved by the US FDA, hemoglobin monitors of compact size will likely drive sales of the hemoglobin monitor market.
With the availability of small hemoglobin monitors, the cost will be reduced, and subsequently, the demand for hemoglobin monitors will increase. It is anticipated that the change in the nature of the product, namely the point-of-care version, will increase the demand for hemoglobin monitors in long-term care.
Technological advancements such as wireless connectivity are anticipated to increase the demand and acceptability of hemoglobin monitors as well as increase the up-gradation of hemoglobin monitors. Patients suffering chronically from diabetes are expected to raise the requirement for these devices.
The limitations to the growth of the hemoglobin monitor market can be downward pricing pressure from respective regulatory bodies to expand the reach of hemoglobin monitors at affordable prices.
Geographically, the hemoglobin monitor market is segmented into seven regions, viz. South Asia, East Asia, Europe, Latin America, North America, Oceania, and the Middle East and Africa.
Blood donation is an important part of the hemoglobin monitoring market. By donating more blood units, more such products could be manufactured, thereby propelling hemoglobin monitor market opportunities. While developed economies will continue to play an important role in the hemoglobin monitor market, emerging economies are also taking the market by storm.
In the hemoglobin monitor market, North America is expected to have a significant share, in part because of its quality infrastructure and installed base, which supports the demand for hemoglobin monitors. It is followed by Europe, East Asia, and Oceania.
Given the current change in adoption and growth in the general pharmaceutical market, the South Asia hemoglobin monitor market could prove lucrative for manufacturers and industry professionals. Other reasons for the lucrative market growth for hemoglobin monitors in South Asia are its large population and its disease burden.
Principal Consultant
The present market structure of the hemoglobin monitor market is expected to change with efforts and research present in the clinical phase.
The involved in the market of hemoglobin monitor market include Masimo Corporation, Bayer AG, Siemens Healthineers, Welch Allyn, Inc., Koninklijke Philips N.V, Medtronic plc, Nihon Kohden Corporation, GE Healthcare, Smiths Group, and Omron Healthcare.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 7.8% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2017 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in US$ billion, and CAGR from 2022 to 2032. |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Product type, modality, end-user, and geography |
| Regional scope | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa |
| Country scope | USA, North America, Canada, Europe, Germany, UK, France, Italy, Spain, Asia Pacific, Japan, China, India, Latin America, Mexico, Brazil, Middle-East and Africa, South Africa, Saudi Arabia |
| Key companies profiled | Masimo Corporation; Bayer AG; Siemens Healthineers; Welch Allyn, Inc.; Koninklijke Philips N.V; Medtronic plc; Nihon Kohden Corporation; GE Healthcare; Smith’s Group and Omron Healthcare. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In the forecast period 2022-2032, the hemoglobin monitor market is expected to rise from US$1 Billion in the year 2020 to US$1.7 Billion by 2032 with a CAGR of 7.8%, which indicates promising growth prospects.
Key players holding substantial hemoglobin monitor market share include Masimo Corporation, Bayer AG, Siemens Healthineers, Welch Allyn, Inc., Koninklijke Philips N.V, Medtronic plc, Nihon Kohden Corporation, GE Healthcare, Smiths Group, and Omron Healthcare.
As per the analysis, the hemoglobin monitor market share is likely to be US$1.7 Billion by 2032.
Because of the approval of the U.S. FDA, hemoglobin monitor sales are likely to increase. Small hemoglobin monitors will lower the cost, increasing their demand. In addition, growth of the hemoglobin monitors market will be driven by technological advances such as wireless connectivity.
Explore Healthcare Insights
View Reports
Hemoglobin Monitor Market
